Dark

Check out our API

ONVO
Organovo Holdings Inc.
stock NASDAQ

Inactive

Apr 23, 2025

2.04USD+1.493%(+0.03)244,953

Pre-market

0.00USD-100.000%(-2.01)0

After-hours

0.00USD0.000%(0.00)0

OverviewOptionsHistoricalExchangesShortsNews

Jan 10, 2022

12:03PM EST Organovo Files Counterclaims In Patent Lawsuit Brought Against It By CellInk Benzinga

12:00PM EST Organovo Files Counterclaims In Patent Lawsuit Brought Against It GlobeNewswire Inc

Nov 30, 2021

04:47PM EST Organovo Holdings Says On Track To Establish Human 3D Model In Inflammatory Bowel Disease In 2022 Benzinga

08:05AM EST Organovo Holdings, Inc. (Nasdaq: ONVO), today provided a business overview and progress update, and announced it is on track to establish its first models of inflammatory bowel disease in 2022 using its 3D bioprinting and other 3D tissue technologies. GlobeNewswire Inc

Oct 6, 2021

05:00PM EDT Organovo Says CFO Jonathan Lieber Notified Of His Intent To Resign, Says Appointed Thomas P. Hess As Newly Appointed President, Chief Financial Officer Benzinga

Sep 22, 2021

02:09PM EDT Organovo Granted EU Patent "ENGINEERED THREE-DIMENSIONAL SKIN TISSUES, ARRAYS THEREOF, AND METHODS OF MAKING THE SAME' Benzinga

Sep 17, 2021

04:10PM EDT Organovo Holdings, Inc. (Nasdaq: ONVO), today announced that the Companys annual meeting of shareholders, on September 14, 2021, at 9:00 a.m. was convened and adjourned, without any business being conducted, due to lack of the required quorum. GlobeNewswire Inc

Jun 1, 2021

03:13PM EDT Organovo Holdings Granted European Patent Titled 'AUTOMATED DEVICES, SYSTEMS, AND METHODS FOR THE FABRICATION OF TISSUE' Benzinga

May 28, 2021

10:21AM EDT Mid-Morning Market Update: Markets Open Higher; Big Lots Posts Upbeat Q1 Profit Benzinga

Apr 19, 2021

04:11PM EDT Organovo Holdings On April 13, CFO Chris Heberlig, Notified Company Of His Intent To Resign From Company, Effective May 7, 2021 Benzinga

Apr 6, 2021

03:31PM EDT Organovo Granted U.S. Patent Titled 'Devices, systems, and methods for the fabrication of tissue' Benzinga

Mar 30, 2021

06:29PM EDT Ark Funds Changes Weighting Caps: Could This Mean A Higher Tesla Allocation? Benzinga

Mar 3, 2021

02:05PM EST ARK Invest's Cathie Wood Says 3D Printing Stocks Have Been In The Place For A While Where 'Sentiment Is So Negative And Something Differentiated Is Going To Happen'; Doesn't Mention A Specific 3D Printing Name Benzinga

Mar 2, 2021

08:05AM EST Organovo Holdings, Inc. (Nasdaq: ONVO), today announced it will be featured as a presenting company at the H.C. Wainwright Global Life Sciences Conference. The conference is being heldon March 9-10, 2021 virtually. GlobeNewswire Inc

Feb 17, 2021

07:02PM EST Cathie Wood's ARK Invest Posts Fund Sales For Wednesday, Feb. 17, 2021: GOOGL, CDNA, TWST, VCYT, ONVO, SPLK, SSYS, BYDDY, AVAV, API, PD, PSTG, TCEHY Benzinga

Jan 19, 2021

05:08PM EST Organovo Holdings Files For Mixed Shelf Of Up To $150M Benzinga

Dec 17, 2020

05:26PM EST 12 Emerging Technologies To Watch In 2021 Benzinga

Sep 30, 2020

03:03PM EDT Organovo Granted European Patent Number EP3126490 Titled 'ENGINEERED THREE-DIMENSIONAL BREAST TISSUE, ADIPOSE TISSUE, AND TUMOR DISEASE MODEL' Benzinga

Sep 3, 2020

04:05PM EDT Organovo Regains Compliance with Nasdaq Minimum Bid Price Requirement GlobeNewswire Inc

Aug 17, 2020

08:17AM EDT Organovo Announces 1-for-20 Reverse Stock Split RTTNews

08:11AM EDT Organovo Declares 1-for-20 Reverse Stock Split Of Common Stock RTTNews

08:07AM EDT Organovo Announces One-For-Twenty Reverse Stock Split Benzinga

Share